Skip to main content
Top
Published in: Tumor Biology 2/2015

01-02-2015 | Research Article

Differential diagnosis between hepatic metastases and benign focal lesions using DWI with parallel acquisition technique: a meta-analysis

Authors: Chenggang Wei, Jieying Tan, Li Xu, Liu Juan, Si Wei Zhang, Lu Wang, Qun Wang

Published in: Tumor Biology | Issue 2/2015

Login to get access

Abstract

We aim to investigate the diagnostic capability of diffusion-weighted imaging using parallel acquisition technique for the differentiation between hepatic metastases and benign focal lesions with a meta-analysis. The meta-analysis included a total of 858 hepatic metastases and 440 benign liver lesions from nine studies. The pooled sensitivity and specificity of diffusion-weighted imaging (DWI) were 0.87 (95 % CI, 0.84–0.89) and 0.90 (95 % CI, 0.87–0.93), respectively. The positive likelihood ratio (PLR) and negative likelihood ratio (NLR) were 8.50 (95 % CI, 4.97–14.52) and 0.17 (95 % CI, 0.11–0.26), respectively. The P value for χ 2 heterogeneity for all pooled estimates was <0.05. From the fitted summary receiver operating characteristics (SROC), the area under the curve (AUC) and Q* index were 0.95 and 0.88, respectively. Publication bias is not present (t = −0.76, P = 0.471). The meta-regression analysis indicated that evaluated covariates included patient number, patient population, mean age, maximum of b factor, number of cysts, number of hemangiomas, and field were not sources of heterogeneity (all P value >0.05). Diffusion-weighted imaging was useful for differentiation between hepatic metastases and benign focal lesions. The diffusion characteristics of the benign hepatocellular lesions, including cases of focal nodular hyperplasia (FNH) and adenoma, have rarely been reported and need further studies. The diagnostic capability of DWI with parallel acquisition technique for differentiation between metastases and benign hepatic focal lesions might be overestimated.
Literature
1.
go back to reference Hardie AD, Naik M, Hecht EM, Chandarana H, Mannelli L, Babb JS, et al. Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI. Eur Radiol. 2010;20:1431–41.CrossRefPubMed Hardie AD, Naik M, Hecht EM, Chandarana H, Mannelli L, Babb JS, et al. Diagnosis of liver metastases: value of diffusion-weighted MRI compared with gadolinium-enhanced MRI. Eur Radiol. 2010;20:1431–41.CrossRefPubMed
2.
go back to reference Benoist S, Nordlinger B. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Ann Surg Oncol. 2009;16:2385–90.CrossRefPubMed Benoist S, Nordlinger B. The role of preoperative chemotherapy in patients with resectable colorectal liver metastases. Ann Surg Oncol. 2009;16:2385–90.CrossRefPubMed
3.
go back to reference Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer. 2007;109:718–26.CrossRefPubMed Cummings LC, Payes JD, Cooper GS. Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer. 2007;109:718–26.CrossRefPubMed
4.
go back to reference Gillams AR, Lees WR. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol. 2009;19:1206–13.CrossRefPubMed Gillams AR, Lees WR. Five-year survival in 309 patients with colorectal liver metastases treated with radiofrequency ablation. Eur Radiol. 2009;19:1206–13.CrossRefPubMed
5.
go back to reference Pozzo C, Barone C, Kemeny NE. Advances in neoadjuvant therapy for colorectal cancer with liver metastases. Cancer Treat Rev. 2008;34:293–301.CrossRefPubMed Pozzo C, Barone C, Kemeny NE. Advances in neoadjuvant therapy for colorectal cancer with liver metastases. Cancer Treat Rev. 2008;34:293–301.CrossRefPubMed
6.
go back to reference Takakura Y, Okajima M, Kanemitsu Y, Kuroda S, Egi H, Hinoi T, et al. External validation of two nomograms for predicting patient survival after hepatic resection for metastatic colorectal cancer. World J Surg. 2011;35:2275–82.CrossRefPubMed Takakura Y, Okajima M, Kanemitsu Y, Kuroda S, Egi H, Hinoi T, et al. External validation of two nomograms for predicting patient survival after hepatic resection for metastatic colorectal cancer. World J Surg. 2011;35:2275–82.CrossRefPubMed
7.
go back to reference Mannelli L, Bhargava P, Osman SF, Raz E, Moshiri M, Laffi G, et al. Diffusion-weighted imaging of the liver: a comprehensive review. Curr Probl Diagn Radiol. 2013;42:77–83.CrossRefPubMed Mannelli L, Bhargava P, Osman SF, Raz E, Moshiri M, Laffi G, et al. Diffusion-weighted imaging of the liver: a comprehensive review. Curr Probl Diagn Radiol. 2013;42:77–83.CrossRefPubMed
8.
go back to reference Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magnet Res Med Off J Soc Magnet Res Med Soc Magnet Res Med. 1999;42:952–62.CrossRef Pruessmann KP, Weiger M, Scheidegger MB, Boesiger P. SENSE: sensitivity encoding for fast MRI. Magnet Res Med Off J Soc Magnet Res Med Soc Magnet Res Med. 1999;42:952–62.CrossRef
9.
go back to reference Kurihara Y, Yakushiji YK, Tani I, Nakajima Y, Van Cauteren M. Coil sensitivity encoding in MR imaging: advantages and disadvantages in clinical practice. AJR Am J Roentgenol. 2002;178:1087–91.CrossRefPubMed Kurihara Y, Yakushiji YK, Tani I, Nakajima Y, Van Cauteren M. Coil sensitivity encoding in MR imaging: advantages and disadvantages in clinical practice. AJR Am J Roentgenol. 2002;178:1087–91.CrossRefPubMed
10.
go back to reference Nasu K, Kuroki Y, Nawano S, Kuroki S, Tsukamoto T, Yamamoto S, et al. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology. 2006;239:122–30.CrossRefPubMed Nasu K, Kuroki Y, Nawano S, Kuroki S, Tsukamoto T, Yamamoto S, et al. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging. Radiology. 2006;239:122–30.CrossRefPubMed
11.
go back to reference Wu LM, Hu J, Gu HY, Hua J, Xu JR. Can diffusion-weighted magnetic resonance imaging (DW-MRI) alone be used as a reliable sequence for the preoperative detection and characterisation of hepatic metastases? A meta-analysis. Eur J Cancer. 2013;49:572–84.CrossRefPubMed Wu LM, Hu J, Gu HY, Hua J, Xu JR. Can diffusion-weighted magnetic resonance imaging (DW-MRI) alone be used as a reliable sequence for the preoperative detection and characterisation of hepatic metastases? A meta-analysis. Eur J Cancer. 2013;49:572–84.CrossRefPubMed
12.
go back to reference Bruegel M, Gaa J, Waldt S, Woertler K, Holzapfel K, Kiefer B, et al. Diagnosis of hepatic metastasis: comparison of respiration-triggered diffusion-weighted echo-planar MRI and five t2-weighted turbo spin-echo sequences. AJR Am J Roentgenol. 2008;191:1421–9.CrossRefPubMed Bruegel M, Gaa J, Waldt S, Woertler K, Holzapfel K, Kiefer B, et al. Diagnosis of hepatic metastasis: comparison of respiration-triggered diffusion-weighted echo-planar MRI and five t2-weighted turbo spin-echo sequences. AJR Am J Roentgenol. 2008;191:1421–9.CrossRefPubMed
13.
go back to reference Holzapfel K, Reiser-Erkan C, Fingerle AA, Erkan M, Eiber MJ, Rummeny EJ, et al. Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of liver metastases in patients operated for pancreatic cancer. Abdom Imaging. 2011;36:179–84.CrossRefPubMed Holzapfel K, Reiser-Erkan C, Fingerle AA, Erkan M, Eiber MJ, Rummeny EJ, et al. Comparison of diffusion-weighted MR imaging and multidetector-row CT in the detection of liver metastases in patients operated for pancreatic cancer. Abdom Imaging. 2011;36:179–84.CrossRefPubMed
14.
go back to reference Kim H, Yu JS, Cho ES, Chung JJ, Kim JH, Kim D, et al. Diffusion-weighted imaging versus superparamagnetic iron oxide (SPIO)-enhanced MRI: exclusive and combined values in the assessment of hepatic metastases. Magnetic resonance imaging 2012;30:554–61. Kim H, Yu JS, Cho ES, Chung JJ, Kim JH, Kim D, et al. Diffusion-weighted imaging versus superparamagnetic iron oxide (SPIO)-enhanced MRI: exclusive and combined values in the assessment of hepatic metastases. Magnetic resonance imaging 2012;30:554–61.
15.
go back to reference Koh DM, Brown G, Riddell AM, Scurr E, Collins DJ, Allen SD, et al. Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination. Eur Radiol. 2008;18:903–10.CrossRefPubMed Koh DM, Brown G, Riddell AM, Scurr E, Collins DJ, Allen SD, et al. Detection of colorectal hepatic metastases using MnDPDP MR imaging and diffusion-weighted imaging (DWI) alone and in combination. Eur Radiol. 2008;18:903–10.CrossRefPubMed
16.
go back to reference Lowenthal D, Zeile M, Lim WY, Wybranski C, Fischbach F, Wieners G, et al. Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging. Eur Radiol. 2011;21:832–40.CrossRefPubMed Lowenthal D, Zeile M, Lim WY, Wybranski C, Fischbach F, Wieners G, et al. Detection and characterisation of focal liver lesions in colorectal carcinoma patients: comparison of diffusion-weighted and Gd-EOB-DTPA enhanced MR imaging. Eur Radiol. 2011;21:832–40.CrossRefPubMed
17.
go back to reference Shimada K, Isoda H, Hirokawa Y, Arizono S, Shibata T, Togashi K. Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases. Eur Radiol. 2010;20:2690–8.CrossRefPubMed Shimada K, Isoda H, Hirokawa Y, Arizono S, Shibata T, Togashi K. Comparison of gadolinium-EOB-DTPA-enhanced and diffusion-weighted liver MRI for detection of small hepatic metastases. Eur Radiol. 2010;20:2690–8.CrossRefPubMed
18.
go back to reference Soyer P, Boudiaf M, Place V, Sirol M, Pautrat K, Vignaud A, et al. Preoperative detection of hepatic metastases: comparison of diffusion-weighted, T2-weighted fast spin echo and gadolinium-enhanced MR imaging using surgical and histopathologic findings as standard of reference. Eur J Radiol. 2011;80:245–52.CrossRefPubMed Soyer P, Boudiaf M, Place V, Sirol M, Pautrat K, Vignaud A, et al. Preoperative detection of hepatic metastases: comparison of diffusion-weighted, T2-weighted fast spin echo and gadolinium-enhanced MR imaging using surgical and histopathologic findings as standard of reference. Eur J Radiol. 2011;80:245–52.CrossRefPubMed
19.
go back to reference Knechtle SJ, Pirsch JD, Fechner HJJ, Becker BN, Friedl A, Colvin RB, et al. Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2003;3:722–30.CrossRef Knechtle SJ, Pirsch JD, Fechner HJJ, Becker BN, Friedl A, Colvin RB, et al. Campath-1H induction plus rapamycin monotherapy for renal transplantation: results of a pilot study. Am J Transplant Off J Am Soc Transplant Am Soc Transplant Surg. 2003;3:722–30.CrossRef
20.
go back to reference Kanematsu M, Goshima S, Watanabe H, Kondo H, Kawada H, Noda Y, et al. Detection and characterization of focal hepatic lesions with diffusion-weighted MR imaging: a pictorial review. Abdom Imaging. 2013;38:297–308.CrossRefPubMed Kanematsu M, Goshima S, Watanabe H, Kondo H, Kawada H, Noda Y, et al. Detection and characterization of focal hepatic lesions with diffusion-weighted MR imaging: a pictorial review. Abdom Imaging. 2013;38:297–308.CrossRefPubMed
21.
go back to reference Xia D, Jing J, Shen H, Wu J. Value of diffusion-weighted magnetic resonance images for discrimination of focal benign and malignant hepatic lesions: a meta-analysis. J Magnet Res Imaging JMRI. 2010;32:130–7.CrossRef Xia D, Jing J, Shen H, Wu J. Value of diffusion-weighted magnetic resonance images for discrimination of focal benign and malignant hepatic lesions: a meta-analysis. J Magnet Res Imaging JMRI. 2010;32:130–7.CrossRef
22.
23.
go back to reference Li Y, Chen Z, Wang J. Differential diagnosis between malignant and benign hepatic tumors using apparent diffusion coefficient on 1.5-T MR imaging: a meta analysis. Eur J Radiol. 2012;81:484–90.CrossRefPubMed Li Y, Chen Z, Wang J. Differential diagnosis between malignant and benign hepatic tumors using apparent diffusion coefficient on 1.5-T MR imaging: a meta analysis. Eur J Radiol. 2012;81:484–90.CrossRefPubMed
25.
go back to reference Ho KM. Forest and funnel plots illustrated the calibration of a prognostic model: a descriptive study. J Clin Epidemiol. 2007;60:746–51.CrossRefPubMed Ho KM. Forest and funnel plots illustrated the calibration of a prognostic model: a descriptive study. J Clin Epidemiol. 2007;60:746–51.CrossRefPubMed
26.
go back to reference Souza JP, Pileggi C, Cecatti JG. Assessment of funnel plot asymmetry and publication bias in reproductive health meta-analyses: an analytic survey. Reprod Health. 2007;4:3.CrossRefPubMedPubMedCentral Souza JP, Pileggi C, Cecatti JG. Assessment of funnel plot asymmetry and publication bias in reproductive health meta-analyses: an analytic survey. Reprod Health. 2007;4:3.CrossRefPubMedPubMedCentral
27.
go back to reference Yeh J, D’Amico F. Forest plots: data summaries at a glance. J Fam Practice. 2004;53:1007. Yeh J, D’Amico F. Forest plots: data summaries at a glance. J Fam Practice. 2004;53:1007.
Metadata
Title
Differential diagnosis between hepatic metastases and benign focal lesions using DWI with parallel acquisition technique: a meta-analysis
Authors
Chenggang Wei
Jieying Tan
Li Xu
Liu Juan
Si Wei Zhang
Lu Wang
Qun Wang
Publication date
01-02-2015
Publisher
Springer Netherlands
Published in
Tumor Biology / Issue 2/2015
Print ISSN: 1010-4283
Electronic ISSN: 1423-0380
DOI
https://doi.org/10.1007/s13277-014-2663-9

Other articles of this Issue 2/2015

Tumor Biology 2/2015 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine